Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-059712
Filing Date
2023-05-12
Accepted
2023-05-12 16:05:17
Documents
1
Period of Report
2023-05-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2315647-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2315647-1_4seq1.xml 4 4301
  Complete submission text file 0001104659-23-059712.txt   5787
Mailing Address 579 BELLEVUE AVE NEWPORT RI 02840
Business Address
DAWES KAREN A (Reporting) CIK: 0001261506 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40367 | Film No.: 23915564

Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Vaccitech plc (Issuer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations